Long-term benefit of SABR for operable early-stage NSCLC shown in new study

A new study from researchers at The University of Texas MD Anderson Cancer Center showed that stereotactic ablative radiotherapy (SABR) was as effective as surgery at providing long-term benefits to patients with operable early-stage non-small cell lung cancer (NSCLC) and generated minimal side effects. The study is the first of its kind to compare long-term results of SABR against surgical treatment in patients with operable early-stage NSCLC.

ASTRO submits comments to CMS: Stop the draconian cuts that will harm cancer patient care

The American Society for Radiation Oncology (ASTRO) submitted two comment letters to the Centers for Medicare and Medicaid Services (CMS) today urging the agency to reconsider policy changes that will result in $300 million in Medicare cuts for radiation therapy services starting January 1, 2022.

American Society for Radiation Oncology (ASTRO) to host in-person Annual Meeting in Chicago, October 24-27

Registration opens today for the American Society for Radiation Oncology’s (ASTRO) 63rd Annual Meeting, which will return to an in-person conference at McCormick Place West in Chicago, October 24-27, 2021. Media resources and registration are available at www.astro.org/astro2021press, and general registration is available at www.astro.org/annualmeeting.

COVID-19 pandemic has led to more advanced-stage cancer diagnoses, physician survey finds

Doctors who oversee cancer clinics say that new patients are arriving for treatment with more advanced disease than before the COVID-19 pandemic, according to a new survey from the American Society for Radiation Oncology (ASTRO). The survey fielded in early 2021 also found that treatment postponements and deferrals have largely subsided.

Errant DNA Boosts Immunotherapy Effectiveness

DALLAS – Dec. 17, 2020 – DNA that ends up where it doesn’t belong in cancer cells can unleash an immune response that makes tumors more susceptible to immunotherapy, the results of two UT Southwestern studies indicate. The findings, published online today in Cancer Cell, suggest that delivering radiation – which triggers DNA release from cells – before immunotherapy could be an effective way to fight cancers that are challenging to treat.

Rutgers Cancer Institute of New Jersey Chair of Radiation Oncology and Associate Vice Chancellor Named President-Elect of the RSNA Board

The Radiological Society of North America (RNSA) is an international society of radiologists, medical physicists and other medical professionals across the world, with the mission of promoting excellence in patient care and health care delivery through education, research and technologic innovation. This year, Bruce G. Haffty, MD, associate vice chancellor for cancer programs and chair, radiation oncology at Rutgers Cancer Institute of New Jersey has been named president-elect of the society.

Radiation oncologists urge Congress to advance bills that protect patient access to cancer care during the pandemic

Radiation oncologists across the country will meet virtually with members of Congress this week to urge lawmakers to pass legislation that will safeguard access to high-quality, value-based health care for people with cancer. The doctors will meet with Congressional leaders and staff as part of the American Society for Radiation Oncology (ASTRO) virtual Advocacy Day, which will take place November 19-20, 2020.

Radiation oncology research and clinical trial results to be featured at ASTRO’s Annual Meeting

The American Society for Radiation Oncology (ASTRO) announced today the press program for its 2020 Annual Meeting, which will feature studies on cancer treatment advances and discussions of topical issues including COVID-19. Researchers will present their findings via live webcasts on October 26 and 27. Register for press access at www.astro.org/annnualmeetingpress.

ASTRO responds to CMS Radiation Oncology Model: Implementation delay and more reforms needed

In response to today’s announcement by the Centers for Medicare and Medicaid Services (CMS) to establish an advanced alternative payment model (APM) for radiation oncology practices starting January 1, 2021, the American Society for Radiation Oncology (ASTRO) issued the following statement from Theodore L. DeWeese, MD, FASTRO, Chair of the ASTRO Board of Directors.

Systematic Testing of Environmental Surfaces in a Radiation Oncology Clinic Shows no Detectable SARS-CoV2

It has been hypothesized that SARS-CoV2 spread among people via droplets that come from the nose and mouth or through contact with contaminated objects and surfaces. Researchers at Rutgers Cancer Institute found that environmental surface testing at the center’s Radiation Oncology Department located within Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, during the height of the COVID-19 pandemic in the state showed no detectable SARS-CoV2 – the virus that causes COVID-19.

Memorial Sloan Kettering Awards and Appointments

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

American Society for Radiation Oncology (ASTRO) to host virtual Annual Meeting, October 25-28

The American Society for Radiation Oncology’s (ASTRO) 62nd Annual Meeting, will be held October 25-28 via an interactive virtual platform. The meeting, Global Oncology: Radiation Therapy in a Changing World, will feature reports from the latest clinical trials; panels on global oncology, health disparities and the novel coronavirus; and an immersive attendee experience in a virtual convention center. Media resources are available at www.astro.org/astro2020press.

MSK Physician-Scientists Recognized with Top Honors by AACR, ASCO, and ASH Organizations

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and honors to our staff, given by the American Association for Cancer Research (AACR), the American Society of Clinical Oncology (ASCO), and the American Society of Hematology (ASH) organizations.

Rutgers Cancer Institute of New Jersey Chair of Radiation Oncology and Associate Vice Chancellor of Cancer Programs Receives Prestigious National Award

Bruce G. Haffty, MD, associate vice chancellor for cancer programs and chair, radiation oncology at Rutgers Cancer Institute of New Jersey has been selected as the 2020 Gold Medal Award winner by the American Society for Radiation Oncology (ASTRO), a prestigious national award recognizing individuals who have made outstanding lifetime contributions in the field of radiation oncology.

ASTRO survey: Fewer patient visits despite enhanced COVID-19 safety measures for radiation oncology clinics

Despite facing challenges such as limited access to PPE during the COVID-19 outbreak, radiation oncology clinics quickly implemented safety enhancements that allowed them to continue caring for cancer patients, according to a new national survey from the American Society for Radiation Oncology (ASTRO). All 222 physician leaders in the survey collected April 16-30 said their practices continued to provide radiation therapy, yet 85% also reported declines in patient visits, and by an average of one-third.

Baylor Scott & White’s Glenda Tanner Vasicek Cancer Treatment Center – Temple Announces Construction of New Radiation Oncology Facility

Baylor Scott & White Health’s Glenda Tanner Vasicek Cancer Treatment Center (VCTC) – Temple announces construction of a new radiation oncology facility that will benefit Central Texas patients being treated for cancer. With new radiation treatment equipment and more room for procedures, the facility will be able to treat up to 70 patients per day.

Congressional leaders support radiation oncology community concerns about proposed Medicare alternative payment model

Members of Congress from both sides of the aisle issued a series of oversight letters to the Centers for Medicare and Medicaid Services (CMS) in recent months to urge the Agency to adjust its proposed radiation oncology advanced alternative payment model (RO Model). CMS is expected to issue its final determination before the end of 2019.

Johns Hopkins Medicine Celebrates Opening of The Johns Hopkins National Proton Center at Sibley Memorial Hospital, in Collaboration With Children’s National

Pediatric and adult cancer patients in the District of Columbia and elsewhere will now have access to one of the most advanced, lifesaving proton technologies offered in the U.S. at the newly opened Johns Hopkins National Proton Center at Sibley Memorial Hospital in collaboration with Children’s National Hospital

American Society for Radiation Oncology (ASTRO) to host Annual Meeting in Chicago, September 15-18

10,000+ health professionals expected to attend world’s largest radiation oncology meeting ARLINGTON, Va., June 20, 2019 — The American Society for Radiation Oncology (ASTRO) will host its 61st Annual Meeting at McCormick Place in Chicago, September 15-18, 2019. The meeting…